[1]Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract,2018,138: 271-281.

[2]Chilelli NC, Burlina S, Lapolla A. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view[J]. NutrMetab Cardiovasc Dis,2013,23(10):913-9.

[3]Maric-Bilkan C. Sex differences in micro- and macrovascular complications of diabetes mellitus[J]. Clin Sci (Lond),2017,131(9):833-846.

[4]Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation[J]. Cardiovasc Diabetol,2018,17(1):57.

[5]Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum[J]. Indian J Endocrinol Metab,2016,20(4):546-51.

[6]Widlansky ME, Hill RB. Mitochondrial regulation of diabetic vascular disease: an emerging opportunity[J]. Transl Res,2018,202: 83-98.

[7]Wu Y, Pan Q, Yan H, et al. Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis[J]. Diabete,2018,67(11):2167-2182.

[8]Shi Y, Fan S, Wang D, et al. FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of ROCK1/Drp1-mediated mitochondrial fission[J]. BiochimBiophys Acta Mol Basis Dis,2018,1864(7):2481-2494.

[9]Dong Y, Fernandes C, Liu Y, et al. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis[J]. Diab Vasc Dis Res,2017,14(1):14-23.

[10] Wang C, Chao Y, Xu W, et al. CTRP13 Preserves Endothelial Function by Targeting GTP Cyclohydrolase 1 in Diabetes[J]. Diabetes,2020,69(1):99-111.

[11] Rahadian A, Fukuda D, Salim HM, et al. Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice[J]. VasculPharmacol,2020,124: .

[12] Zhang H, Liu J, Qu D, et al. Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes[J]. Proc Natl Acad Sci U S A,2018,115(29):E6927-E6936.

[13] Luppi P, Drain P. C-peptide antioxidant adaptive pathways in β cells and diabetes[J]. J Intern Med,2017,281(1):7-24.

文章来源：《糖尿病天地(临床)》 网址: http://www.tnbtd.cn/qikandaodu/2021/0509/1212.html